The RFA 8b/Pre-Clinical Award from the Pharmacotherapies for Alcohol and Substance Use Disorders Alliance (PASA), funded by the Congressionally Directed Medical Research Programs (CDMRP), supports pre-clinical animal research studies focused on Alcohol and Substance Use Disorders (ASUD). The program is open to researchers in the USA and worldwide. The award provides up to 600,000 USD (indirect and direct costs) for up to 18 months.
Pre-Application Submission Deadline: April 15, 2026. Application Submission Deadline: June 17, 2026.